background image

Liver Cancer Clinical Trials

Find clinical trials for liver cancer. Search for liver cancer clinical trials in different cities and states across the United States.

Filter
1
Active & Responsive

A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)

for
Advanced Liver Cancers
Location: 13 recruiting locations
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT04524871

Phase1, Phase2, Recruiting
Active & Responsive

Zanzalintinib (XL-092) Plus Durvalumab and Tremelimumab in Unresectable Hepatocellular Carcinoma (ZENOBIA)

for
Hepatocellular Carcinoma
Location: 1 recruiting location
Sponsor: Anwaar Saeed

Sex: All

Age: 18+

Code: NCT06698250

Phase2, Recruiting
Active & Responsive

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

for
Pleural Effusion, Malignant, Ascites, Malignant, Carcinoma,
Location: 1 recruiting location
Sponsor: Travera Inc

Sex: All

Age: 18+

Code: NCT05461430

Recruiting
Active & ResponsiveNew

Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma

for
Advanced Unresectable Hepatocellular Carcinoma
Location: 2 recruiting locations
Sponsor: Riboscience, LLC.

Sex: All

Age: 18+

Code: NCT07175441

Phase2, Recruiting
Active & Responsive

DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma

for
Fibrolamellar Hepatocellular Carcinoma (FLC)
Location: 1 recruiting location
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 12+

Code: NCT04248569

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

for
Fibrolamellar Hepatocellular Carcinoma
Location: 1 recruiting location
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 12+

Code: NCT06027086

Phase1, Phase2, Recruiting
Active & Responsive

A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor

for
Endometrial Neoplasms, Neoplasms, Carcinoma, Hepatocellular,
Location: 23 recruiting locations
Sponsor: Eisai Inc.

Sex: All

Age: 18+

Code: NCT04008797

Phase1, Phase2, Recruiting
Active & Responsive

A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function

for
Hepatic Impairment, Advanced Malignant Solid Tumor
Location: 2 recruiting locations
Sponsor: Epizyme, Inc.

Sex: All

Age: 18+

Code: NCT04241835

Phase1, Recruiting
Active & Responsive

FOG-001 in Locally Advanced or Metastatic Solid Tumors

for
Cancer, Colorectal Cancer, Solid Tumor,
Location: 20 recruiting locations
Sponsor: Parabilis Medicines, Inc.

Sex: All

Age: 18+

Code: NCT05919264

Phase1, Phase2, Recruiting
New

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies

for
Cancer, Immunotherapy, Advanced Solid Tumors Cancer,
Location: 6 recruiting locations
Sponsor: Elephas

Sex: All

Age: 18+

Code: NCT07327489

Recruiting